1 Followers
24 Following
mmvaidya

healthcare-industry-dynamics

You will get to know some interesting and daily updates in the global healthcare industry, Here.

NGS Sample Preparation - On-Going Technological Advancements

The NGS sample preparation market comprises several stakeholders such as NGS equipment manufacturers, vendors, and distributors, NGS sequencing services companies, research laboratories and academic institutes, healthcare institutions (hospitals and diagnostic clinics), pharmaceutical and biotechnology companies, contract manufacturing organizations (CMOs), and contract research organizations (CROs).

The demand side of this market is characterized by significant use of NGS sample preparation due to the increasing use of NGS in diagnostics and decreasing cost of NGS platforms. The supply side is characterized by advancements in NGS platforms and other products. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.

Market Size Estimation:

Both top-down and bottom-up approaches were used to estimate and validate the total size of the NGS sample preparation market. These methods were also used extensively to estimate the size of various sub segments in the market.

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=69735098

The research methodology used to estimate the market size includes the following:

The key players in the industry and markets have been identified through extensive secondary research.

The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research.

All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Report Objectives:

To define, describe, and forecast the NGS sample preparation market based on product, application, end user, and region

To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges) along with the current trends

To strategically analyze micromarkets with respect to their individual growth trends, future prospects, and contributions to the total market

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders

To forecast revenue of the market segments with respect to four regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)

To profile the key players and comprehensively analyze their market shares and core competencies

To track and analyze competitive developments such as product launches; agreements, partnerships, and collaborations; and mergers & acquisitions; in the NGS sample preparation market

Factors Influencing Global Growth:-

Factors such as advancements in NGS platforms, reduced cost of sequencing, and improving reimbursement scenario for NGS-based diagnostic tests are driving the growth of this market.

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=69735098

Restraints:
End User Budget Constraints in Developing Countries

Opportunities:
Initiatives and Funding From Government & Private Bodies for Large-Scale Sequencing Projects
Increasing Applications of NGS

Challenges:
Ethical Issues

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The global NGS sample preparation market is projected to reach USD 2.7 billion by 2024 from USD 1.1 billion in 2018, at a CAGR of 18.7% during the forecast period.

Geographical Growth Scenario:

Geographically, the NGS sample preparation market is segmented into North America (US and Canada), Europe (Germany, France, the UK, and the Rest of Europe), Asia Pacific (China, Japan, India, and the Rest of Asia Pacific), and the Rest of the World (RoW). North America accounted for the largest share of the overall NGS sample preparation market in 2018 followed by Europe.

The large share of North America can be attributed to the favorable initiatives by government and private bodies for the development and adoption of NGS technologies, wide adoption of NGS diagnostics in the region, increasing number of NGS-based research & clinical applications in the region, growing research on cancer, rising awareness of NGS services, and the presence of leading NGS service providers, in the region.

Leading Market Players:

#
 Illumina Inc. (US)
Thermo Fisher Scientific (US)
QIAGEN N.V. (Germany)
Agilent Technologies, Inc. (US) and many more…

Analysis of the developments in the NGS sample preparation market from 2016 to 2018 shows that product launches; agreements, partnerships and collaborations; expansions; and acquisitions were the most widely adopted growth strategies by players in the market. Players adopted these strategies to strengthen their market positions.

Read More Detailed Article@
https://www.marketsandmarkets.com/Market-Reports/ngs-sample-preparation-market-69735098.html

Healthcare Contract Management Software - Global Industry Dynamics

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Objectives behind This Study:

#
 To define, describe, and forecast the global healthcare contract management software market by product & service, end user, and region

To provide detailed information about the factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)

To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

To forecast the size of the healthcare contract management software market in four regions (along with major countries)—North America, Europe, Asia Pacific, and Rest of the World.

To profile key players in the healthcare contract management software market and comprehensively analyze their core competencies and market shares

To track and analyze competitive developments such as mergers and acquisitions; new product/technology launches; expansions; collaborations, partnerships, and agreements; and R&D activities of the leading players in the global healthcare contract management software market

Please Share your Specific Interest So That We Can Serve You Better |
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=114258694

Recent Developments:

In October 2018, Icertis opened two new offices in Sydney and Singapore to meet the rising market demand.
In February 2018, Cobblestone Software launched a new mobile contract management software app for Android and Apple iOS devices.
In October 2018, Contract Logix launched the Express Contract Management Software and Premium Contract Lifecycle Management.
In December 2018, Determine Inc. entered into an agreement with Axbility Consulting (US) that provided greater opportunities to Determine.
In March 2017, nThrive Inc. acquired e4e Healthcare Services to expand its service offerings.

Key Questions Addressed by the Report:

Where will all these developments take the industry in the mid-to-long term?
What are the major end users and the benefits they avail by implementing healthcare contract management software?
What are the trends going on in the healthcare contract management software market?
What are the major market dynamics and their impact on market growth?
What is the global scenario of the healthcare contract management software market?

Factors Influencing Global Growth:-

The growing need to reduce operational costs (while increasing the operational efficiency of healthcare organizations) and the growing need to maintain compliance with regulatory mandates are key drivers of this market.

Restraints:
Reluctance to Switch from Conventional Methods
IT Infrastructural Limitations in Developing Countries

Opportunities:
Declining Reimbursements and Competitive Rivalry among Healthcare Payers

Challenges:
Security Concerns
# Dearth of Skilled IT Professionals

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=114258694

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The healthcare contract management software market is projected to reach USD 1,763 million by 2024 from USD 755 million in 2019, at a CAGR of 18.5% during the forecast period.

Geographical Growth Scenario:

North America is expected to account for the largest share of the healthcare contract management software market in 2019, followed by Europe. The large share of North America can be attributed to the favorable regulations (such as the Meaningful Use and Health Insurance Portability & Accountability Act) combined with the large number of hospitals and the presence of a number of private insurance players. In addition, well-established government payers are further supporting the growth of this market.

Leading Market Players:

#
 Determine Inc. (US)
CobbleStone Software (US)
Concord (US)
Contract Logix LLC (US)
Icertis (US)
Apttus Corporation (US) and many more…

Read More Detailed Article@
https://www.marketsandmarkets.com/Market-Reports/healthcare-contract-management-software-market-114258694.html

Bioprocess Validation - Emerging Tech Advancements | A Boon to Global Pharma Industry

This study involved the extensive use of primary and secondary sources and involved an in-depth analysis of the various factors affecting the growth of the global bioprocess validation market. Both primary and secondary research was used to identify the segmentation types, trends, key players, key market dynamics, and key player strategies as well as derive the competitive leadership mapping and competitive landscape in this market.

Objectives behind This Study:

#
 To define, describe, and forecast the bioprocess validation services market based on test type, process component, end-user, and region.

To provide detailed information regarding the factors influencing market growth (such as drivers, restraints, opportunities, challenges, and industry trends)

To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall bioprocess validation services market.

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players operating in this market.

To strategically profile the key players in the bioprocess validation services market and comprehensively analyze their market shares and core competencies

To strategically analyze five different geographical regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

To track and analyze competitive developments such as joint ventures & acquisitions; product developments and enhancements; agreements & partnerships; expansions; and funding activities in the bioprocess validation services market.

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39981433

Recent Developments:

In August 2018, Merck KGaA launched the BioReliance Product Characterization Portfolio to enhance its service portfolio in the bioprocess validation market.

In March 2017, Toxikon and SG Lab (Italy) entered into a partnership, to extend its analytical and extractable & leachable testing service portfolio to determine the drug integrity in the entire life cycle.

In January 2019, SGS acquired LeanSis Expertos en Productividad S.L. (Spain). This acquisition provided SGS operational and manufacturing training and capacity building services to over 200 clients across Spain.

In February 2018, Pall Corporation expanded its Hoegaarden office in Belgium with new R&D center, customer demonstration labs, and manufacturing space. This will help the company to establish its position in the Belgium market.

Key Questions Addressed by the Report:

Where will all these developments take the industry in the medium-to-long-term?
What are the major trends in bioprocess validation?
Who are the major end-users of bioprocess validation?
Which test types are used mainly for bioprocess validation?
Which process component has a higher adoption rate of bioprocess validation?

Factors Influencing Global Growth:-

Stringent safety and quality regulations governing product certification and testing across the biopharmaceutical and pharmaceutical industries, high demand for the outsourcing of bioprocess validation services, and regulatory mandates in the healthcare industry to maintain compliance with Good Manufacturing Practices (GMP) are the major factors driving the growth of this market.

Restraints:
Issues Related to Extractables & Leachables

Opportunities:
Growth Opportunities in Asia Pacific and Latin American Countries
Patent Expiry

Challenges:
Waste Disposal
Development of New Validation Methods for Next Generation Bioproducts

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=39981433

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: This market exceeded USD 180 million in 2019 and is projected to be valued over USD 360 million by 2024, at a CAGR of 14.6% during the forecast period.

Geographical Growth Scenario:

North America is expected to account for the largest share of the bioprocess validation market in 2019, closely followed by Europe. Factors such as the presence of well-established biopharmaceutical industry in the region, high R&D expenditure, presence of leading bioprocess validation service providers, and stringent regulatory requirements for biopharmaceutical production are driving the growth of the bioprocess validation market in North America.

Leading Market Players:

#
 Merck KGaA (Germany)
Sartorius Stedim Biotech (Sartorius AG) (France)
Pall Corporation (US)
# SGS S.A. (Switzerland)
Eurofins Scientific (Luxembourg)
Cobetter Filtration Equipment Co., Ltd. (China) and many more…

Read More Detailed Article@
https://www.marketsandmarkets.com/Market-Reports/bioprocess-validation-market-39981433.html

Tracheostomy Products - Emerging Technological Innovations

Tracheostomy Products - Emerging Technological Innovations

The study involved four major activities in estimating the current size of the tracheostomy products market. Exhaustive secondary research was carried out to collect information on the market and its different sub segments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of segments and sub segments.

Objectives behind This Study:

#
 To define, describe, and forecast the tracheostomy market based on product, technique, end user, region, and country

To provide detailed information on the major factors influencing market growth (such as drivers, restraints, opportunities, and industry-specific challenges)

To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and their contributions to the overall tracheostomy market

To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

To forecast the market value of various segments and sub-segments with respect to five regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

To profile the key players in the tracheostomy market and comprehensively analyze their global revenue shares and core competencies.

To track and analyze competitive market-specific developments such as product launches, partnerships, expansions, and acquisitions

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=79626751

Recent Developments:

In February 2019, Medtronic Plc entered into a partnership with Medical University of South Carolina (US) for the development of better and affordable healthcare solutions (including tracheostomy procedure for breathing assistance) for patients

In October 2017, Medtronic Plc established the Chengdu Innovation Center at Singapore for cross-disciplinary clinical training and R&D.

Key Questions Addressed by the Report:

Emerging countries are offering immense opportunities for the growth and adoption of market. Will this scenario continue in the coming years?
Where will all the advancements in products offered by various companies take the industry in the mid-to-long term?
What are the various research institutes where tracheostomy products find a high adoption rate?
What are the new trends and advancements in the market?
How is the shift in dynamics shaping the future of the market?

Factors Influencing Global Growth:-

Growth in the tracheostomy products industry is driven primarily by the growing public awareness related to tracheostomy procedures among medical professionals, increasing prevalence of respiratory diseases & disorders, and availability of medical reimbursement and insurance coverage.

Restraints:
High Cost of Tracheostomy Procedures
Increasing Pricing Pressure on Market Players

Opportunities:
Emerging Markets

Challenges:
Dearth of Skilled Surgeons

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=79626751

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The tracheostomy products market size is projected to reach USD 220 million by 2024 from USD 179 million in 2019, at a CAGR of 4.2%.

Geographical Growth Scenario:

The market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the market in 2018.

Factors such as the presence of a highly developed healthcare system, an increasing number of emergency department visits, high adoption of innovative tracheostomy devices among medical professionals, and wide availability of advanced tracheostomy devices are driving the market for tracheostomy products in North America.

Leading Market Players:

#
 Medtronic plc (Ireland)
Smiths Group plc (UK)
TRACOE Medical GmbH (Germany)
Teleflex Incorporated (US)
# Fisher & Paykel Healthcare Ltd. (New Zealand) and many more…

The analysis of market developments between 2015 and 2019 revealed that several growth strategies such as collaborations and market expansions were adopted by players to strengthen their product portfolio and maintain a competitive position in the tracheostomy products market.

Read More Detailed Article@
https://www.marketsandmarkets.com/Market-Reports/tracheostomy-product-market-79626751.html

ATP Assay Market - Global Industry Growth Predictions

The study involved four major activities in estimating the current size of the ATP assays market. Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets. The next step is to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both the top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the sizes of segments and sub segments.

Objectives behind This Study:

To define, describe, segment, and forecast the ATP assays market based on product, application, end user, and region

To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, and opportunities)

To analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market

To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market players

To forecast the size of the market in five main regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa

To profile key players in the ATP assays market and comprehensively analyze their core competencies and market shares

To track and analyze competitive developments such as mergers, acquisitions, collaborations, agreements, and partnerships reported by leading players in the market

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223438780

Recent Developments:

In March 2019, Promega launched the Water-Glo reagent, which uses bioluminescent technology to measure ATP and is used for monitoring microbial contamination in freshwater, process water, seawater, or wastewater samples.

In August 2018, Hygiena acquired Biomedal’s Food Safety division. Under this acquisition, the new division will be named Hygiena Diagnóstica España and will provide allergen tests and assays in the market.

In February 2018, Merck invested around USD 44 million (~EUR 40 million) for expanding its manufacturing and distribution centers in South Korea, India, and China.

In August 2017, Hach (a subsidiary of Danaher Corporation) expanded its Loveland, US campus by inaugurating a new facility for R&D.

Key Questions Addressed by the Report:

#
 Which are the top 10 players operating in the ATP assays market?
What are the drivers, restraints, opportunities, and challenges of the market?
What are the prevailing industry trends, and what is the current scenario in the market?
What are the growth trends in the market at the segmental and overall levels?
How is the market performing in different regions across the globe?

Factors Influencing Global Growth:-

Growth in this market is majorly driven by the increasing demand for ATP assays in pharmaceutical & biotechnology companies, rising investments in pharmaceutical & biotechnology R&D, the increasing prevalence of cancer and other chronic and infectious diseases, and the shift from culture-based tests to rapid tests.

Restraints:
# High Cost of Instruments

Opportunities:
# Technology Enhancements in ATP Assay Probes
Growth Prospects in Emerging Markets
Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=223438780

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The global ATP assays market size is projected to reach USD 315 million by 2024 from USD 191 million in 2019, at a CAGR of 10.5%.

Geographical Growth Scenario:

Asia Pacific is expected to witness the highest growth in the ATP assays market from 2019 to 2024

The global ATP assays market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. During the forecast period, the Asia Pacific market is estimated to grow at the highest CAGR, as several countries are witnessing a growing number of proteomics, genomics, and stem cell research activities, increasing research funding, rising investments by pharmaceutical & biotechnology companies, and the growing trend of research infrastructure modernization.

Leading Market Players:

Merck KGaA (Germany)
Thermo Fisher Scientific, Inc. (US)
PerkinElmer, Inc. (US)
Lonza Group (Switzerland)
Promega Corporation (US)
Agilent Technologies, Inc. (US) and many more…

The ATP assays market is highly consolidated, with a few players competing for a larger market share. The top ten players account for more than half of the total market share, while other global and regional market players account for the remaining share.

Read More Detailed Article@
https://www.marketsandmarkets.com/Market-Reports/atp-assay-market-223438780.html

Patient Blood Management Market - Global Industry Dynamics

The study involved four major activities to estimate the current size of the patient blood management market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the size of the segments and sub segments.

The research methodology used to estimate the market size includes the following:

Product mapping of various manufacturers for each product type of patient blood management at the regional and/or country level

Relative adoption pattern of each patient blood management system among key end users at the regional and/or country level

Detailed primary research to gather quantitative information related to segments and sub segments at the region and/or country-level

Detailed secondary research to gauge prevailing market trends at the region and/or country-level

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131352979

Recent Developments:

In 2019, Abbott (US) received the US FDA approval for its ‘Alinity s’ blood culture screening system as well as the Afinion HbA1c Dx assay kit.

In 2019, F. Hoffmann-La Roche LTD (Switzerland) received the US FDA approval for its cobas Babesia Test for donor screening.

In 2018, Terumo BCT (Japan) and Stafa Cellular Therapy (US) entered into a collaborative agreement. Based on this agreement, Terumo BCT expands access to the StafaCT software to healthcare organizations.

In 2018, B. Braun Melsungen AG (Ireland) acquired the bloodlines business of NxStage Medical, Inc. (US), which operates under the Medisystems brand.

In 2018, Abbott (US) received a CE mark for its Alinity h-series to be used in the European Union.

Key Questions Addressed by the Report:

What are the growth opportunities related to the adoption of patient blood management solutions across the globe in the future?

# Which product segment will register the highest adoption rate during the forecast period?

# Where will the advancements in products offered by various companies take the industry in the mid- to long-term?

# Emerging countries have immense opportunities for the growth of the market. Will this scenario continue in the next five years?

# Which end users are estimated to adopt patient blood management systems?

# What are the key strategies adopted by the key players operating in the market?

Factors Influencing Global Growth:-

The rising prevalence of blood disorders and the increasing number of blood donations & blood donors will fuel market growth over the forecast period. Moreover, the rising prevalence of target diseases and technological advancements in the patient blood management industry will further fuel the growth of the market in the near future.

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=131352979

Restraints:
High Cost Associated With Automated Systems

Opportunities:
Market Penetration Opportunities in Developing Countries
# Growing Awareness Regarding the Safety of Donated Blood

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The global patient blood management market size is projected to reach USD 15.3 billion by 2024 from USD 10.7 billion in 2019, at a CAGR of 7.4% from 2019 to 2024.

Geographical Growth Scenario:

The Asia Pacific region is expected to register significant growth during the forecast period of 2019-2024

The patient blood management market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

The Asia Pacific blood management market is expected to register significant growth over the forecast period due to the modernization of healthcare infrastructure, increasing prevalence of chronic lifestyle diseases, and rising awareness about blood donation & blood safety. China accounted for a major share of the Asia Pacific market, owing to a large patient pool and favorable government guidelines to improve healthcare infrastructure in the country.

Leading Market Players:

#
 Haemonetics Corporation (US)
Fresenius SE & Co. KGaA (Germany)
# Terumo Corporation (Japan)
Immucor, Inc. (US)
B. Braun Melsungen AG (Ireland)
Macopharma (US)) and many more…

An analysis of market developments between 2016 and 2019 revealed that several growth strategies such as product launches and enhancements, collaborations, partnerships, agreements, and strategic acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the patient blood management market.

Read More Detailed Article@
https://www.marketsandmarkets.com/Market-Reports/patient-blood-management-market-131352979.html

Technological Advancements in the Patient Blood Management Industry

The study involved four major activities to estimate the current size of the patient blood management market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the size of the segments and sub segments.

 

The research methodology used to estimate the market size includes the following:

 

Product mapping of various manufacturers for each product type of patient blood management at the regional and/or country level

 

Relative adoption pattern of each patient blood management system among key end users at the regional and/or country level

 

Detailed primary research to gather quantitative information related to segments and subsegments at the region and/or country-level

 

Detailed secondary research to gauge prevailing market trends at the region and/or country-level

 

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131352979

 

Recent Developments:

 

In 2019, Abbott (US) received the US FDA approval for its ‘Alinity s’ blood culture screening system as well as the Afinion HbA1c Dx assay kit.

 

In 2019, F. Hoffmann-La Roche LTD (Switzerland) received the US FDA approval for its cobas Babesia Test for donor screening.

 

In 2018, Terumo BCT (Japan) and Stafa Cellular Therapy (US) entered into a collaborative agreement. Based on this agreement, Terumo BCT expands access to the StafaCT software to healthcare organizations.

 

In 2018, B. Braun Melsungen AG (Ireland) acquired the bloodlines business of NxStage Medical, Inc. (US), which operates under the Medisystems brand.

 

In 2018, Abbott (US) received a CE mark for its Alinity h-series to be used in the European Union.

 

Key Questions Addressed by the Report:

 

What are the growth opportunities related to the adoption of patient blood management solutions across the globe in the future?

# Which product segment will register the highest adoption rate during the forecast period?

# Where will the advancements in products offered by various companies take the industry in the mid- to long-term?

# Emerging countries have immense opportunities for the growth of the market. Will this scenario continue in the next five years?

# Which end users are estimated to adopt patient blood management systems?

# What are the key strategies adopted by the key players operating in the market?

 

Factors Influencing Global Growth:-

 

The rising prevalence of blood disorders and the increasing number of blood donations & blood donors will fuel market growth over the forecast period. Moreover, the rising prevalence of target diseases and technological advancements in the patient blood management industry will further fuel the growth of the market in the near future.

 

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=131352979

 

Restraints:

High Cost Associated With Automated Systems

 

Opportunities:

Market Penetration Opportunities in Developing Countries

# Growing Awareness Regarding the Safety of Donated Blood

 

Monetary Growth Expectations, Globally:

 

According to the Research Study conducted by MarketsandMarkets™: The global patient blood management market size is projected to reach USD 15.3 billion by 2024 from USD 10.7 billion in 2019, at a CAGR of 7.4% from 2019 to 2024.

 

Geographical Growth Scenario:

 

The Asia Pacific region is expected to register significant growth during the forecast period of 2019-2024

 

The patient blood management market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

 

The Asia Pacific blood management market is expected to register significant growth over the forecast period due to the modernization of healthcare infrastructure, increasing prevalence of chronic lifestyle diseases, and rising awareness about blood donation & blood safety. China accounted for a major share of the Asia Pacific market, owing to a large patient pool and favorable government guidelines to improve healthcare infrastructure in the country.

 

Leading Market Players:

 

# Haemonetics Corporation (US)

Fresenius SE & Co. KGaA (Germany)

# Terumo Corporation (Japan)

Immucor, Inc. (US)

B. Braun Melsungen AG (Ireland)

Macopharma (US)) and many more…

 

An analysis of market developments between 2016 and 2019 revealed that several growth strategies such as product launches and enhancements, collaborations, partnerships, agreements, and strategic acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the patient blood management market.

 

Read More Detailed Article@

https://www.marketsandmarkets.com/Market-Reports/patient-blood-management-market-131352979.html

Protein Assays Market - Emerging Trends | Future Forecasts | Industry Leaders | Revenue Growth Expectations

Protein Assays Market - Emerging Trends | Future Forecasts | Industry Leaders | Revenue Growth Expectations

Protein assays are used in life science research to determine the total protein concentration. Estimation of protein concentration is necessary for protein purification, electrophoresis, cell biology, molecular biology, and research applications.

 

Target Audience for this Report:

 

# Protein assay manufacturers and vendors

# Distributors of protein assays

# Various research and consulting companies

# Associations related to pharmaceutical and biotechnological research

 

Value Addition for the Buyer:

 

This report aims to provide insights into the global protein assays market. Details on regional markets for these segments are also presented in this report. In addition, leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

 

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=93720547

 

Factors Influencing Global Growth:-

 

The increasing pharmaceutical & biotech R&D expenditure and the favorable government funding scenario for proteomics research are the major factors that are expected to drive the growth of the market during the forecast period.

 

Restraints:

# High Cost of Multiplex Assay Equipment

# Sequestration Cuts in the U.S.

 

Opportunities:

# Emerging Markets

# Biomarker Identification

 

Challenges:

# Dearth of Skilled Professionals

# Issues Related to the Development of Protein Assays for Various Disease Types

 

Monetary Growth Expectations, Globally:

 

According to the Research Study conducted by MarketsandMarkets™: The global protein assays market is expected to reach USD 2.41 Billion by 2022 from USD 1.42 Billion in 2017, at a CAGR of 11.1% from 2017 to 2022.

 

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=93720547

 

Geographical Growth Scenario:

 

On the basis of region, the global protein assays market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. The growth in this region is primarily driven by the increasing pharmaceutical and biotechnology R&D expenditure and availability of government funding for life sciences research.

 

Leading Market Players:

 

# Thermo Fisher Scientific (U.S.)

# Bio-Rad Laboratories, Inc. (U.S.)

# Merck KGaA (Germany)

# Cell Signaling Technology, Inc. (U.S.)

# General Electric Company (U.S.)

# PerkinElmer Inc. (U.S.) and many more…

 

Based on the analysis of strategic developments undertaken by market players between 2014 and 2017, the key strategy followed by most companies in the market is expansions and agreements, partnerships, and collaborations.

 

Read More Detailed Article@

https://www.marketsand.markets.com/Market-Reports/protein-assay-market-93720547.html

...This is Why Global Medical Equipment Maintenance Industry is Under Constant Transformation

Recent Developments in the Global Industry:

In 2018, Koninklijke Philips N.V. (Netherlands) signed a partnership agreement with Kliniken der Stadt Köln (Germany) to provide continuous modernization and maintenance of imaging systems

In 2018, Koninklijke Philips N.V. (Netherlands) signed a partnership agreement with Städtische Klinikum München (Germany) to provide medical imaging solutions which include healthcare consultancy services

In 2016, Biomedical Srl sugned an agreement with ASST Orobica (Spain) for provision of integrated services for the management and maintenance of healthcare devices and equipment

Critical questions the report answers:

Where will all these developments take the industry in the long term?
# What are the upcoming trends for the medical equipment repair market?
# Which segment provides the most opportunity for growth?
# Who are the leading vendors operating in this market?
What are the opportunities for new market entrants?

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=69695102

Factors Influencing Global Growth:-

The major factors that are expected to be driving the medical equipment repair market are rising focus on preventive medical equipment maintenance, growth in associated equipment markets, adoption of innovative funding mechanisms, and the increasing purchase of refurbished medical equipment.

Restraints:
High Initial Cost and Significant Maintenance Expenditure

Opportunities:
Innovation in Service Offerings and Use of IoT
Emergence of ISOs

Challenges:
# Survival of Players in a Highly Fragmented and Competitive Market

The objective of This Study:

#
 To define, describe, and forecast the medical equipment repair market size based on device type (imaging equipment, Electromedical Equipment, Endoscopic Devices, Surgical Instruments, and Other Medical Equipment), service type, service provider, end user, and region.

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The Medical Equipment Maintenance Market is expected to reach USD 74.1 billion by 2027 from USD 28.9 billion in 2018, at a CAGR of 10.4% during the forecast period.

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=69695102

Geographical Growth Scenario:

North America is expected to lead the medical equipment maintenance market in 2023

On the basis of the region, the medical equipment maintenance market is segmented into North America, Europe, Asia, and the RoW. In 2018, North America is expected to account for the largest share of the market, followed by Europe, The largest share of the North American market is attributed to the factors such as the rise in aging population and incidence of lifestyle-related diseases, access to quality healthcare, well-established healthcare infrastructure, high adoption of advanced technology, and the presence of prominent players.

In 2018, Europe is expected to hold the second-largest share. Factors such as expanding patient population, rising focus on early diagnosis, growing number of diagnostic imaging procedures, and strategic agreements, partnerships, and collaborations between service providers and end users are expected to fuel market growth in this region.

Leading Market Players:

#
 GE Healthcare (US)
Koninklijke Philips N.V. (Netherlands)
Siemens Healthineers (Germany)
Toshiba Medical Systems Europe (Germany)
FUJIFILM Holdings Corporation (Japan)
Carestream Health, Inc. (U.S.) and many more…

The medical equipment maintenance market is highly fragmented in nature, with several big as well as emerging players vying for market shares.

These players have adopted various strategies, such as partnerships, agreements, collaborations, and product launches to further expand their presence in the global medical equipment maintenance market. Partnerships, collaborations, and agreements have been the key growth strategies adopted during 2016 to 2018, by players such as Hitachi, Ltd. (Japan), Medtronic plc (Ireland), and Althea Group (Italy).

Read More Detailed Article@
https://www.marketsandmarkets.com/Market-Reports/medical-equipment-maintenance-market-69695102.html

Global Surgical Imaging Industry - Forthcoming Innovations

Following are the major objectives of the study:

 

# To describe and forecast the surgical imaging market, in terms of value, by technology, application, and region

 

# To describe and forecast the market, by region–Asia Pacific (APAC), Europe, North America, and Rest of the World (RoW) along with their respective countries

 

# To provide detailed information regarding major factors influencing market growth (drivers, restraints, opportunities, and challenges)

 

# To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

 

# To study the complete value chain of surgical imaging

 

# To analyze opportunities in the market for stakeholders by identifying the high-growth segments of the surgical imaging ecosystem

 

# To strategically profile key players and comprehensively analyze their market position in terms of ranking and core competencies, along with detailing competitive landscape for market leaders

 

# To analyze strategic approaches such as partnerships, agreements, alliances, collaborations, product launches, expansions, and acquisitions in the market

 

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=210534462

 

Factors Influencing Global Growth:-

 

The key factors driving the growth of this market are growing popularity of Flat Panel Detector C-arms (FPD C-arms) owing to advantages of FPDs over image intensifiers, reimbursement cuts on analog radiography systems, and increasing demand for minimally invasive procedures.

 

Restraints:

# High Cost of Instruments

 

Opportunities:

# Growing Demand for Data-Integrated Imaging Systems

# Emerging Markets to Offer High Growth Opportunities

 

Challenges:

# Imaging Obese Patients

 

Monetary Growth Expectations, Globally:

 

According to the Research Study conducted by MarketsandMarkets™: The surgical imaging market is expected to reach USD 1.63 Billion by 2022 from an estimated USD 1.25 Billion in 2017, at a CAGR of 5.5%.

 

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=210534462

 

Major Developments in the Global Industry:

 

# In 2017, Koninklijke Philips partnered with Government of Kenya and the United Nations to Establish the SDG (Sustainable Development Goals) Partnership Platform in Kenya to make primary healthcare more accessible

 

# In 2017, Koninklijke Philips established its first innovation center in Moscow, Russia

 

# In 2017, Siemens Received US FDA approval for its Cios Fusion, Cios Connect, and Cios Select

 

# In 2017, Ziehm Imaging Launched the new version of Ziehm Vision FD with a complementary metal oxide semiconductor (CMOS) flat-panel detector and a new CMOS flat-panel detector which allows for display of smaller pixels in the same quality

 

# In 2016, Shimadzu Corporation established an indirectly-owned subsidiary—Shimadzu Malaysia Sdn Bhd.

 

Geographical Growth Scenario:

 

North America is expected to account for the largest share of the surgical imaging market in 2017, followed by Europe, Asia Pacific (APAC), and the Rest of the World. The large share of this region can be attributed to a rising number of overuse sports injuries, and rising prevalence of CVD, along with the increasing number of cardiac arrest cases, and increase in the number of minimally invasive procedures performed in Canada.

 

However, Asia Pacific is expected to register the highest CAGR of 7.1% during the forecast period, owing to the rapid growth in geriatric population in Japan, healthcare reforms in China, improving healthcare infrastructure in India, and rising number of orthopedic and CVD procedures in Australia.

 

Leading Market Players:

 

# GE Healthcare (US)

# Koninklijke Philips (Netherlands)

# Siemens (Germany)

# Ziehm Imaging (Germany)

# Hologic (US)

# Shimadzu Corporation (Japan) and many more…

 

Agreements, collaborations, alliances, and partnerships were the key strategies adopted by players from 2014–2017. The players that adopted these strategies are Koninklijke Philips, Ziehm Imaging, GE Healthcare, Siemens, OrthoScan, Toshiba Medical Systems, and Medtronic.

 

Koninklijke Philips accounted for a share of 38% of the total number of agreements, collaborations, alliances, and partnerships in the surgical imaging market. This high share of the company can be attributed to its increasing number of partnerships and collaborations with hospitals which are the primary end users of C-arms.

 

Read More Detailed Article@

https://www.marketsandmarkets.com/Market-Reports/surgical-imaging-market-210534462.html

Stem Cell Banking Market - Emerging Industry Dynamics

Objectives of this study are:

#
 To define, describe, and forecast the stem cell banking market by source, service type, application, and region

# To provide detailed information about factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)

# To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

# To analyze the market opportunities for stakeholders and provide details of the competitive landscape for key players

# To forecast the market size for North America, Europe, Asia Pacific, and the Rest of the World (RoW)

# To profile key players and comprehensively analyze their global market shares and core competencies

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=220680183

Factors Influencing Global Growth:-

Market growth can primarily be attributed to the increase in hematopoietic stem cell transplantation (HSCT) procedures, development of novel technologies for stem cell processing, preservation, and storage, increasing investments in stem cell-based research, and growing awareness on the therapeutic potential of stem cells.

Restraints:
High Operational Costs of Stem Cell Banking
Stringent Regulatory Frameworks

Opportunities:
Emerging Countries
# Rising Global Burden of Major Diseases

Market Challenge:
# Socio-Ethical Concerns Related to Embryonic Stem Cells 

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The global stem cell banking market over the forecast period of 2019 to 2027. The market is projected to reach USD 13.86 billion by 2027 from USD 7.26 billion in 2019, at a CAGR of 8.4%.

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=220680183

Geographical Growth Scenario:

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share in 2019. The expanding network of stem cell banking services across the region, ongoing approval of stem cell lines for disease treatment (especially for hematopoietic & autoimmune disorders), recent technological advancements in the field of stem cell collection and preservation techniques, and rising public-private investments for stem cell researches are driving the growth of the stem cell banking market in North America.

Leading Market Players:

#
 Cord Blood Registry (CBR) Systems (US)
Cordlife Group Limited (Singapore)
Cryo-Cell International (US)
ViaCord (US)
Cryo-Save AG (Netherlands)
LifeCell International (India) and many more…

These are the several growth strategies such as service launches & upgrades; agreements, partnerships, & collaborations; and mergers & acquisitions were adopted by the market players to strengthen and competitive position in the global stem cell banking market. Among these business strategies, agreements, partnerships, & collaborations were the most widely adopted growth strategies by majority of market players worldwide.

Human Liver Models Market - Emerging Industry Dynamics

Objectives of the Study

 

# To define, measure, and describe the global human liver model market by type and region

 

# To provide detailed information about the major factors influencing market growth (drivers, restraints, challenges, and opportunities)

 

# To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

 

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

 

# To forecast the size of market segments in North America, Europe, Asia Pacific, and RoW

 

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171046468

 

Factors Influencing Global Growth:-

 

The key factors driving the growth of this market include growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of liver models, growing initiatives to increase awareness about liver organoids, increasing research activities on liver organoids, increasing prevalence of non-alcoholic fatty liver disease, and growing need for the early detection of drug toxicity to minimize financial losses due to late-stage drug failure.

 

Restraints:

# Issues Related to the Incorporation of Organoids Into Existing Workflows

 

Opportunities:

# Increasing Focus on Drug Discovery Activities

# Rising Demand for Liver Transplantation

# Growing Healthcare Market in the Asia Pacific and Latin America

 

Monetary Growth Expectations, Globally:

 

According to the Research Study conducted by MarketsandMarkets™: The global human liver models market is expected to reach USD 2.56 Billion by 2022 from USD 1.35 Billion in 2017, at a CAGR of 13.6% during the forecast period (2017-2022).

 

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=171046468

 

Geographical Growth Scenario:

 

Geographic segments in this report include North America, Europe, Asia Pacific, and the RoW. Of these, the North American segment accounted for the largest share of the market in 2017. The human liver market for North America is driven by the presence of a well-established life sciences industry, growing awareness about the organoids technology, increasing government funding, growing incidence of NAFLD, and unavailability of livers for transplantation, increasing investments on research, rising focus on tissue culture-based clinical diagnostics, and the availability of skilled professionals.

 

Leading Market Players:

 

# Emulate (US)

# Ascendance Bio (US)

# HìREL (US)

# CN Bio (UK)

# Organovo (US)

# Cyfuse Biomedical (Japan) and many more…

Veterinary Pain Management Market - Major Growth Boosters

Years considered for this report:

 

2017 – Base Year

2018 – Estimated Year

2023 – Projected Year

 

Objectives of the Study

 

# To define, describe, and forecast the global veterinary pain management market on the basis of product, application, animal type, distribution channel, and region

 

# To provide detailed information about factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)

 

# To strategically analyze micromarkets with respect to the individual growth trends, prospects, and contributions to the overall market

 

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

 

# To forecast the size of the market segments in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

 

# To profile key players and comprehensively analyze their market shares and core competencies in the global market

 

# To track and analyze competitive developments such as partnerships, agreements, & collaborations; mergers & acquisitions; product developments; and geographical expansions in the global market

 

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96167677

 

Factors Influencing Global Growth:-

 

Market growth can be attributed to growth in companion animal adoption, increasing number of veterinary practitioners and their rising income levels in developed economies, growing prevalence of animal disease causing pain and inflammation, and rising adoption of pet insurance with growing animal health.

 

Restraints:

# Increasing Pet Care Costs

 

Opportunities:

# Increasing Popularity of Non-Conventional and Non-Pharmaceutical Treatment Techniques

# Untapped Emerging Markets

 

Monetary Growth Expectations, Globally:

 

According to the Research Study conducted by MarketsandMarkets™: The veterinary pain management market is projected to reach USD 1.66 Billion by 2023 from USD 1.13 Billion in 2018, at a CAGR of 8.0% during the forecast period.

 

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=96167677

 

Geographical Growth Scenario:

 

Global veterinary pain management market has been studied for North America, Europe, Asia Pacific (APAC), Latin America, and Middle East & Africa. APAC is expected to grow at the highest CAGR in veterinary pain management market, primarily due to the significant growth in pet adoption, increasing awareness about animal health, and growing per capita animal health expenditure, especially in India and China.

 

Leading Market Players:

 

# Zoetis (US)

# Merck Animal Health (US)

# Elanco (US)

# Chanelle (Ireland)

# Boehringer Ingelheim (Germany)

# Vetoquinol (France) and many more…

 

The global veterinary pain management drugs market is a consolidated market, and the top three pharmaceutical companies account for a large share of the global market. Boehringer Ingelheim (Germany), Zoetis (US), Elanco (US), dominated the veterinary pain management drugs market in 2017.

 

Read the Detailed Research Article, Here@

https://www.marketsandmarkets.com/Market-Reports/veterinary-pain-management-market-96167677.html

High Potency APIs Industry - Emerging Trends & Global Future Forecasts

Target Audience for this Report:

 

# Manufacturers of HPAPI

# Distributors and suppliers of HPAPIs

# Potential investors in the HPAPI market

# Pharmaceutical companies

# Biotechnology companies

# Contract manufacturing organizations

# Life science research centers

# Healthcare payers

 

Objectives of the Study:

 

# To define, describe, and forecast the global HPAPI market on the basis of type, type of manufacturer, type of synthesis, therapeutic application, and region

 

# To provide detailed information about factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)

 

# To strategically analyze micromarkets with respect to the individual growth trends, prospects, and contributions to the overall market

 

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

 

# To forecast the size of the market segments of North America, Europe, Asia, and the Rest of the World (RoW)

 

# To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies

 

# To track and analyze competitive developments such as agreements, partnerships, collaborations, and alliances; mergers and acquisitions; expansions; and R&D activities in the global market

 

Please Share your Specific Interest So That We Can Serve You Better | Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36582475

 

Factors Influencing Global Growth:-

 

The growth in this market is driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies, and growing focus on precision medicine.

 

Restraints:

# Requirement of Large Investments

# Discrepancies in Hpapi Banding Systems

# Uncertainties Associated With Products

# High Risk of Cross-Contamination

 

Opportunities:

# Growing Opportunities for Cmos and Cdmos

# Emerging Markets

 

Monetary Growth Expectations, Globally:

 

According to the Research Study conducted by MarketsandMarkets™: The global HPAPI market is expected to reach USD 26.84 Billion by 2023 from USD 16.49 Billion in 2017, at a CAGR 8.7%. The base year considered for the study is 2017 and the forecast period is from 2018 to 2023.

 

Please Share your Specific Interest So That We Can Serve You Better | Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=36582475

 

Geographical Growth Scenario:

 

In 2018, North America is expected to account for the largest share of the market followed by Europe. Factors such growing incidence of cancer, increasing investments in cancer research, technological advancements in HPAPI manufacturing, growing CMOs market, constructive government reforms like the Patient Protection and Affordable Care Act, growing focus of leading pharmaceutical companies in the HPAPIs segment, and increasing demand for antibody-drug conjugates (ADCs) are responsible for the large share of North America in the global HPAPIs market.

 

Leading Market Players:

 

# Pfizer (US)

# Novartis International AG (Switzerland)

# Sanofi (France)

# Boehringer Ingelheim (Germany)

# Bristol-Myers Squibb (US)

# Teva (Israel) and many more…

 

Agreements, partnerships, collaborations, and alliances accounted for the largest share of the overall growth strategies followed by key players between 2015 and 2018.

 

Read the Detailed Research Article, Here@

https://www.marketsandmarkets.com/Market-Reports/high-potency-api-market-36582475.html